Statement Of Cash Flows

OncoTherapy Science, Inc. - Filing #7300533

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-575,685,000 JPY
-877,289,000 JPY
Income taxes paid
-2,425,000 JPY
-2,561,000 JPY
Interest paid
-655,000 JPY
JPY
Net cash provided by (used in) operating activities
-578,766,000 JPY
-879,851,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
JPY
-2,627,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
JPY
-33,570,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
1,174,772,000 JPY
683,770,000 JPY
Net cash provided by (used in) financing activities
1,149,384,000 JPY
677,229,000 JPY
Net increase (decrease) in cash and cash equivalents
570,617,000 JPY
-236,192,000 JPY
Cash and cash equivalents
1,098,274,000 JPY
527,656,000 JPY
881,443,000 JPY
1,117,635,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.